American Healthcare REIT, Inc. (NYSE:AHR) Stock Position Lowered by BNP Paribas Financial Markets

BNP Paribas Financial Markets lessened its position in American Healthcare REIT, Inc. (NYSE:AHR) by 95.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 17,035 shares of the company’s stock after selling 355,238 shares during the period. BNP Paribas Financial Markets’ holdings in American Healthcare REIT were worth $445,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of American Healthcare REIT by 34.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,537 shares of the company’s stock worth $66,000 after buying an additional 654 shares in the last quarter. Kozak & Associates Inc. acquired a new stake in shares of American Healthcare REIT during the third quarter worth $28,000. Tidemark LLC acquired a new stake in shares of American Healthcare REIT during the third quarter worth $44,000. Kessler Investment Group LLC acquired a new stake in shares of American Healthcare REIT during the third quarter worth $48,000. Finally, KBC Group NV acquired a new stake in shares of American Healthcare REIT during the third quarter worth $51,000. Institutional investors own 16.68% of the company’s stock.

Analyst Upgrades and Downgrades

AHR has been the topic of a number of recent analyst reports. Colliers Securities raised American Healthcare REIT from a “hold” rating to a “moderate buy” rating in a research report on Sunday, October 13th. KeyCorp boosted their target price on American Healthcare REIT from $16.00 to $27.00 and gave the stock an “overweight” rating in a research report on Monday, September 16th. Royal Bank of Canada boosted their target price on American Healthcare REIT from $28.00 to $30.00 and gave the stock an “outperform” rating in a research report on Monday, November 18th. Bank of America upped their price target on American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Tuesday, September 24th. Finally, JMP Securities upped their price target on American Healthcare REIT from $18.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, September 20th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, American Healthcare REIT has an average rating of “Moderate Buy” and an average target price of $25.13.

American Healthcare REIT Stock Performance

Shares of NYSE AHR opened at $28.47 on Friday. The business’s 50-day moving average price is $26.83 and its two-hundred day moving average price is $21.42. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.37 and a quick ratio of 0.37. American Healthcare REIT, Inc. has a one year low of $12.63 and a one year high of $29.99. The company has a market capitalization of $4.36 billion and a P/E ratio of -59.31.

American Healthcare REIT (NYSE:AHR) last issued its earnings results on Tuesday, November 12th. The company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.35). American Healthcare REIT had a negative net margin of 1.84% and a negative return on equity of 1.87%. The firm had revenue of $523.81 million during the quarter, compared to analysts’ expectations of $474.26 million. The business’s quarterly revenue was up 12.8% compared to the same quarter last year. Analysts anticipate that American Healthcare REIT, Inc. will post 1.42 earnings per share for the current fiscal year.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.